<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Dis Model Mech</journal-id>
<journal-id journal-id-type="publisher-id">DMM</journal-id>
<journal-id journal-id-type="hwp">dmm</journal-id>
<journal-title-group>
<journal-title>Disease Models &amp; Mechanisms</journal-title>
</journal-title-group>
<issn pub-type="ppub">1754-8403</issn>
<issn pub-type="epub">1754-8411</issn>
<publisher>
<publisher-name>The Company of Biologists</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26398952</article-id>
<article-id pub-id-type="pmc">4631792</article-id>
<article-id pub-id-type="doi">10.1242/dmm.022525</article-id>
<article-id pub-id-type="publisher-id">DMM022525</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Hyperactivity and attention deficits in mice with decreased levels of stress-inducible phosphoprotein 1 (STIP1)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Beraldo</surname>
<given-names>Flavio H.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thomas</surname>
<given-names>Anu</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kolisnyk</surname>
<given-names>Benjamin</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hirata</surname>
<given-names>Pedro H.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Jaeger</surname>
<given-names>Xavier</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martyn</surname>
<given-names>Amanda C.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Jue</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goncalves</surname>
<given-names>Daniela F.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cowan</surname>
<given-names>Matthew F.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Masood</surname>
<given-names>Talal</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martins</surname>
<given-names>Vilma R.</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gros</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prado</surname>
<given-names>Vania F.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af4">4</xref>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prado</surname>
<given-names>Marco A. M.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af4">4</xref>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>Robarts Research Institute, The University of Western Ontario</institution>, <addr-line>London, Ontario N6A5B7</addr-line>, <country>Canada</country></aff>
<aff id="af2"><label>2</label><addr-line>Program in Neuroscience</addr-line>, <institution>The University of Western Ontario</institution>, <addr-line>London, Ontario N6A5B7</addr-line>, <country>Canada</country></aff>
<aff id="af3"><label>3</label><addr-line>Department of Molecular and Cell Biology</addr-line>, <institution>International Research Center, A.C. Camargo Cancer Center and National Institute for Translational Neuroscience Research Center</institution>, <addr-line>Sao Paulo, SP 01508-010</addr-line>, <country>Brazil</country></aff>
<aff id="af4"><label>4</label><addr-line>Department of Physiology and Pharmacology</addr-line>, <institution>The University of Western Ontario</institution>, <addr-line>London, Ontario N6A5B7</addr-line>, <country>Canada</country></aff>
<aff id="af5"><label>5</label><addr-line>Department of Anatomy and Cell Biology</addr-line>, <institution>The University of Western Ontario</institution>, <addr-line>London, Ontario N6A5B7</addr-line>, <country>Canada</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label>Authors for correspondence (<email>fberaldo@robarts.ca</email>; <email>vprado@robarts.ca</email>; <email>mprado@robarts.ca</email>)</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>11</month>
<year>2015</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
<volume>8</volume>
<issue>11</issue>
<fpage>1457</fpage>
<lpage>1466</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>9</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Â© 2015. Published by The Company of Biologists Ltd</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="dmm-8-022525.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Stress-inducible phosphoprotein I (STIP1, STI1 or HOP) is a co-chaperone intermediating Hsp70/Hsp90 exchange of client proteins, but it can also be secreted to trigger prion protein-mediated neuronal signaling. Some mothers of children with autism spectrum disorders (ASD) present antibodies against certain brain proteins, including antibodies against STIP1. Maternal antibodies can cross the fetus blood-brain barrier during pregnancy, suggesting the possibility that they can interfere with STIP1 levels and, presumably, functions. However, it is currently unknown whether abnormal levels of STIP1 have any impact in ASD-related behavior. Here, we used mice with reduced (50%) or increased STIP1 levels (fivefold) to test for potential ASD-like phenotypes. We found that increased STIP1 regulates the abundance of Hsp70 and Hsp90, whereas reduced STIP1 does not affect Hsp70, Hsp90 or the prion protein. Interestingly, BAC transgenic mice presenting fivefold more STIP1 show no major phenotype when examined in a series of behavioral tasks, including locomotor activity, elevated plus maze, Morris water maze and five-choice serial reaction time task (5-CSRTT). In contrast, mice with reduced STIP1 levels are hyperactive and have attentional deficits on the 5-CSRTT, but exhibit normal performance for the other tasks. We conclude that reduced STIP1 levels can contribute to phenotypes related to ASD. However, future experiments are needed to define whether it is decreased chaperone capacity or impaired prion protein signaling that contributes to these phenotypes.</p>
</abstract>
<abstract abstract-type="precis">
<p><bold>Summary:</bold> Here, using a series of behavioral tests including touchscreen tasks we show that decreased levels of stress-inducible phosphoprotein 1 (STIP1) lead to attention deficits and hyperactivity in mice.</p>
</abstract>
<kwd-group>
<title>KEY WORDS</title>
<kwd>Touchscreen</kwd>
<kwd>Autism</kwd>
<kwd>ASD</kwd>
<kwd>Stress-inducible phosphoprotein 1</kwd>
<kwd>Attention deficits</kwd>
<kwd>Mouse model</kwd>
<kwd>BAC</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>special-property</meta-name>
<meta-value>TIB</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>INTRODUCTION</title>
<p>In autism spectrum disorders (ASD), alterations in genetic variance and neurodevelopmental are both thought to contribute to phenotype heterogeneity. Womb environment and autoimmune responses have been proposed to contribute to the complex behavioral alterations observed in ASD, which include, but are not limited to, abnormal socialization and communication and stereotyped behavior (<xref ref-type="bibr" rid="DMM022525C10">Brimberg et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C25">Goldani et al., 2014</xref>). Several distinct groups have investigated the existence of antibodies against fetal brain tissue in mothers of ASD children (<xref ref-type="bibr" rid="DMM022525C3">Bauman et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C7">Braunschweig et al., 2012b</xref><xref ref-type="bibr" rid="DMM022525C8">, 2013</xref>; <xref ref-type="bibr" rid="DMM022525C15">Dalton et al., 2003</xref>; <xref ref-type="bibr" rid="DMM022525C42">Nordahl et al., 2013</xref>). Passive transfer of maternal anti-brain antibodies to pregnant experimental animal models (including mice, rats and non-human primates) has shown that their offspring develop a number of endophenotypes that resemble phenotypes in ASD (<xref ref-type="bibr" rid="DMM022525C3">Bauman et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C7">Braunschweig et al., 2012b</xref>; <xref ref-type="bibr" rid="DMM022525C15">Dalton et al., 2003</xref>). Indeed, a recent study indicated that the prevalence of antibodies against fetal brain proteins is increased fourfold in mothers of an ASD child compared with control groups (<xref ref-type="bibr" rid="DMM022525C10">Brimberg et al., 2013</xref>). Proteomics analysis has identified six brain proteins as targets for ASD antibodies, including lactate dehydrogenase A and B (LDH), cypin, stress-inducible phosphoprotein protein1 (STIP1), collapsine response mediator proteins 1 and 2 (CRMP1, CRMP2) and Y-box-binding protein (YBX1) (<xref ref-type="bibr" rid="DMM022525C8">Braunschweig et al., 2013</xref>). Interestingly, injection of maternal antibodies that recognize LDH, STIP1 and CRMP1 in developing mouse embryos causes an increase in cortical neural precursor proliferation and cortical neuron volume, with consequent increase in brain size and weight (<xref ref-type="bibr" rid="DMM022525C35">Martinez-Cerdeno et al., 2014</xref>). These phenotypes are consistent with the notion that the presence of maternal autoantibodies can affect neuronal development.</p>
<p>STIP1, also known as heat-shock organizing protein (Hop) or STI1, is a co-chaperone that interacts concomitantly with heat-shock proteins 70 and 90 (Hsp70 and HsP90) (<xref ref-type="bibr" rid="DMM022525C1">Abbas-Terki et al., 2002</xref>; <xref ref-type="bibr" rid="DMM022525C13">Chen et al., 1996</xref>; <xref ref-type="bibr" rid="DMM022525C41">Nicolet and Craig, 1989</xref>; <xref ref-type="bibr" rid="DMM022525C44">Picard, 2002</xref>; <xref ref-type="bibr" rid="DMM022525C48">Smith et al., 1993</xref>). The chaperone machinery is thought to provide a buffer for cells to respond to environmental challenges; disturbance of Hsp70/90 chaperone activity decreases cellular resilience to stress (<xref ref-type="bibr" rid="DMM022525C14">Chen et al., 2015</xref>; <xref ref-type="bibr" rid="DMM022525C29">Hashimoto-Torii et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022525C50">Taipale et al., 2010</xref><xref ref-type="bibr" rid="DMM022525C51">, 2014</xref>). The absence of STIP1 in mice has important consequences for development, including increased apoptosis, DNA damage and death (<xref ref-type="bibr" rid="DMM022525C5">Beraldo et al., 2013</xref>). These phenotypes are rescued by transgenic BAC expression of STIP1 (<xref ref-type="bibr" rid="DMM022525C5">Beraldo et al., 2013</xref>).</p>
<p>In addition to its intracellular role as a co-chaperone, STIP1 is also secreted by a variety of cells (<xref ref-type="bibr" rid="DMM022525C18">Erlich et al., 2007</xref>; <xref ref-type="bibr" rid="DMM022525C19">Eustace and Jay, 2004</xref>; <xref ref-type="bibr" rid="DMM022525C28">Hajj et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C33">Lima et al., 2007</xref>; <xref ref-type="bibr" rid="DMM022525C53">Wang et al., 2010</xref>) via extracellular vesicles (<xref ref-type="bibr" rid="DMM022525C28">Hajj et al., 2013</xref>). Extracellular STIP1 can signal via the prion protein (PrP<sup>C</sup>) to produce a myriad of effects related to brain development (<xref ref-type="bibr" rid="DMM022525C4">Beraldo et al., 2010</xref><xref ref-type="bibr" rid="DMM022525C5">, 2013</xref>; <xref ref-type="bibr" rid="DMM022525C11">Caetano et al., 2008</xref>; <xref ref-type="bibr" rid="DMM022525C34">Lopes et al., 2005</xref>; <xref ref-type="bibr" rid="DMM022525C49">Soares et al., 2013</xref>). Here, we used <italic>Stip1</italic> heterozygous mice (<italic>STI1</italic><sup>â/+</sup> mice), as well as mice overexpresssing four- to fivefold more STIP1 (<italic>STI1</italic><sup>TGA</sup> mice), to investigate the consequences of alteration of STIP1 levels <italic>in vivo</italic>. We report that decreased, but not increased, STIP1 levels affect attention and cause hyperactivity in mice, two phenotypes that are related to ASD-like phenotypes. Our results suggest that interference with STIP1 functions, which presumably occur in the presence of STIP1 antibodies, has the potential to contribute to ASD-like phenotypes.
<boxed-text id="tib" orientation="portrait" position="float"><caption><title>TRANSLATIONAL IMPACT</title></caption><p><bold>Clinical issue</bold></p><p>Autism spectrum disorders (ASD) represent a range of neurodevelopmental disorders with no cure. ASD is characterized by difficulties in communication and socialization, repetitive movements, hyperactivity, impulsivity, and an impaired ability to concentrate and attend to simple tasks. Genetic variance and neurodevelopmental alterations are both thought to contribute to the heterogeneity of the ASD phenotype. Recent studies have demonstrated that some mothers of children with ASD produce antibodies against six specific proteins present in the fetal brain; presumably, these antibodies can interfere with protein function in the developing brain. One of these antibodies targets a protein known as stress inducible phosphoprotein 1 (STIP1). Moreover, a polymorphism for STIP1 was recently identified as a potential risk factor in attention deficit hyperactivity disorder, which shares some phenotypes with ASD. STIP1 is a co-chaperone that mediates the Hsp70/Hsp90 exchange of client proteins. It also triggers prion protein-mediated neuronal signaling.</p><p><bold>Results</bold></p><p>Here, to investigate the potential involvement of STIP1 in ASD, the authors examine mice that express reduced (50%) or increased (fivefold) levels of STIP1. They show that increased STIP1 levels regulate the abundance of Hsp70 and Hsp90. By contrast, reduced STIP1 levels have no effect on Hsp70, Hsp90 or prion protein levels. Notably, however, mice expressing increased levels of STIP1 show no major phenotype when examined using a range of behavioral tasks, whereas mice expressing reduced levels of STIP1 exhibit attention deficits and are hyperactive.</p><p><bold>Implications and future directions</bold></p><p>Because attention deficits and hyperactivity are present in ASD, these findings suggest that interference with STIP1 functions (but not increased STIP1 levels) can contribute to ASD-like phenotypes. Changes in STIP1 levels, possibly triggered by the presence of maternal anti-STIP1 antibodies during brain development, might interfere with the development of brain circuits that affect ASD-like behavior. Additional experiments are required to determine whether decreased STIP1 contributes to ASD-like phenotypes by decreasing chaperone capacity in the developing brain, by impairing prion protein signaling, or through some other mechanism, and to define fully the consequences of disturbed STIP1 activity in ASD.</p></boxed-text></p>
</sec>
<sec id="s2" sec-type="results">
<title>RESULTS</title>
<p>We initially confirmed previous data to show that <italic>STI1</italic><sup>â/+</sup> mice present 50% of <italic>STIP1</italic> mRNA levels in their brain, whereas <italic>STI1</italic><sup>TGA</sup> mice express almost sixfold more mRNA (<xref ref-type="fig" rid="DMM022525F1">Fig.Â 1</xref>A; one-way ANOVA; revealed main effect of genotype <italic>F</italic><sub>(2.15)</sub>=8.521, <italic>P</italic>&lt;0.0001). In contrast, mRNA levels of known STIP1 interaction partners PrP<sup>C</sup> (<xref ref-type="fig" rid="DMM022525F1">Fig.Â 1</xref>B; one-way ANOVA <italic>F</italic><sub>(2.16)</sub>=1.475, <italic>P</italic>=0.2580), Hsp70 (<xref ref-type="fig" rid="DMM022525F1">Fig.Â 1</xref>C; one-way ANOVA <italic>F</italic><sub>(2.16)</sub>=0.301, <italic>P</italic>=0.744) and Hsp90 (<xref ref-type="fig" rid="DMM022525F1">Fig.Â 1</xref>D; one-way ANOVA <italic>F</italic><sub>(2.8)</sub>=1.249, <italic>P</italic>=0.337) were not altered in the brain of the two lines, compared with control mice.
<fig id="DMM022525F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p><bold>Analyses of mRNA for STIP1 partners in <italic>STI1</italic><sup>+/+</sup>, <italic>STI1</italic><sup>â/+</sup> and <italic>STI1</italic><sup>TGA</sup> mouse brains.</bold> (A) <italic>STIP1</italic> mRNA expression (<italic>n</italic>=9 <italic>STI1</italic><sup>+/+</sup>, <italic>n</italic>=5 <italic>STI1</italic><sup>TGA</sup> and <italic>n</italic>=4 <italic>STI1</italic><sup>â/+</sup>). (B) <italic>PrP<sup>C</sup></italic> mRNA expression (<italic>n</italic>=8 <italic>STI1</italic><sup>+/+</sup>, <italic>n</italic>=4 <italic>STI1</italic><sup>TGA</sup> and <italic>n</italic>=7 <italic>STI1</italic><sup>â/+</sup>). (C) <italic>Hsp70</italic> mRNA expression (<italic>n</italic>=8 <italic>STI1</italic><sup>+/+</sup>, <italic>n</italic>=4 <italic>STI1</italic><sup>TGA</sup> and <italic>n</italic>=7 <italic>STI1</italic><sup>â/+</sup>). (D) <italic>Hsp90</italic> mRNA expression (<italic>n</italic>=3 <italic>STI1</italic><sup>+/+</sup>, <italic>n</italic>=4 <italic>STI1</italic><sup>TGA</sup> and <italic>n</italic>=4 <italic>STI1</italic><sup>â/+</sup>). Results are presented as meansÂ±s.e.m.; data were analyzed and compared by one-way ANOVA and Bonferroni multiple comparisons post-hoc test; **<italic>P</italic>&lt;0.001 and ***<italic>P</italic>&lt;0.0001 compared with control.</p></caption><graphic xlink:href="dmm-8-022525-g1"></graphic></fig></p>
<p>Protein levels for STIP1 followed mRNA levels for both <italic>STI1</italic><sup>TGA</sup> (<xref ref-type="fig" rid="DMM022525F2">Fig.Â 2</xref>A; t<sub>(15)</sub>=4.721, <italic>P</italic>=0.003) and <italic>STI1</italic><sup>â/+</sup> (<xref ref-type="fig" rid="DMM022525F2">Fig.Â 2</xref>B; t<sub>(14)</sub>=6.433, <italic>P</italic>&lt;0.0001). PrP<sup>C</sup> protein levels were not different from controls in both lines (<xref ref-type="fig" rid="DMM022525F2">Fig.Â 2</xref>C,D; t<sub>(10)</sub>=1.049, <italic>P</italic>=0.391 and t<sub>(13)</sub>=1.128, <italic>P</italic>=0.279, respectively). Interestingly, levels of Hsp70 were decreased by 50% in <italic>STI1</italic><sup>TGA</sup> brains (<xref ref-type="fig" rid="DMM022525F2">Fig.Â 2</xref>E; t<sub>(7)</sub>=5.846, <italic>P</italic>=0.0006), whereas no change in Hsp70 levels was detected in <italic>STI1</italic><sup>â/+</sup> mice (<xref ref-type="fig" rid="DMM022525F2">Fig.Â 2</xref>F; t<sub>(7)</sub>=0.123, <italic>P</italic>=0.9051), compared with controls. Additionally, Hsp90 levels detected with a pan Hsp90 antibody were doubled in <italic>STI1</italic><sup>TGA</sup> brains (<xref ref-type="fig" rid="DMM022525F2">Fig.Â 2</xref>G; t<sub>(22)</sub>=4.618, <italic>P</italic>=0.0001) but not changed in <italic>STI1</italic><sup>â/+</sup> brains (<xref ref-type="fig" rid="DMM022525F2">Fig.Â 2</xref>H; t<sub>(10)</sub>=0.308, <italic>P</italic>=0.7639), compared with controls. We then evaluated expression levels of Hsp90Î± (inducible form) and Hsp90Î² (constitutive form) in the brains of <italic>STI1</italic><sup>TGA</sup> mice and observed that both forms were significantly increased (<xref ref-type="fig" rid="DMM022525F2">Fig.Â 2</xref>I,J; t<sub>(22)</sub>=4.618, <italic>P</italic>=0.0016 and t<sub>(16)</sub>=5.954, <italic>P</italic>&lt;0.0001, respectively).
<fig id="DMM022525F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p><bold>Analyses of protein levels for STIP1 partners in <italic>STI1</italic><sup>+/+</sup>, <italic>STI</italic><sup>â/+</sup> and <italic>STI1</italic><sup>TGA</sup> mouse brains.</bold> (A,B) STIP1 expression in <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=9 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=8 <italic>STI1</italic><sup>TGA</sup>) and <italic>STI1</italic><sup>â/+</sup> mice (<italic>n</italic>=8 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=8 <italic>STI1</italic><sup>â/+</sup>). (C,D) PrP<sup>C</sup> expression in <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=6 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=6 <italic>STI1</italic><sup>TGA</sup>) and <italic>STI1</italic><sup>â/+</sup> mice (<italic>n</italic>=6 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=9 <italic>STI1</italic><sup>â/+</sup>). (E,F) Hsp70 expression in <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=5 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=4 <italic>STI1</italic><sup>TGA</sup>) and <italic>STI1</italic><sup>â/+</sup> mice (<italic>n</italic>=5 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=4 <italic>STI1</italic><sup>â/+</sup>). (G,H) HSP90 expression in <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=10 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=14 <italic>STI1</italic><sup>TGA</sup>) and <italic>STI1</italic><sup>â/+</sup> mice (<italic>n</italic>=6 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=6 <italic>STI1</italic><sup>â/+</sup>). (I,J) Hsp90Î² (<italic>n</italic>=10 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=8 <italic>STI1</italic><sup>TGA</sup>) and Hsp90Î± (<italic>n</italic>=5 <italic>STI1</italic><sup>+/+</sup> and <italic>n</italic>=4 <italic>STI1</italic><sup>TGA</sup>) in <italic>STI1</italic><sup>TGA</sup> mice. Results are presented as meansÂ±s.e.m.; data were analyzed and compared by Student's <italic>t-</italic>test; *<italic>P</italic>&lt;0.05 and ***<italic>P</italic>&lt;0.0001 compared with control.</p></caption><graphic xlink:href="dmm-8-022525-g2"></graphic></fig></p>
<p>Spontaneous locomotor activity in a new environment can provide information on neuropsychiatric phenotypes in mice associated with genetic mutations. The increased number of <italic>Stip1</italic> copies, with concomitant overexpression of Hsp90 and decreased expression of Hsp70 in <italic>STI1</italic><sup>TGA</sup> mice did not seem to have any major impact on spontaneous locomotion (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>A,B; t<sub>(29)</sub>=1.140, <italic>P</italic>=0.942) or time spent in the center of the box, which provides insight on anxiety-like behavior (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>C; t<sub>(29)</sub>=1.236, <italic>P</italic>=0.8669). In contrast, locomotor activity and total locomotion in a new environment were increased in <italic>STI1</italic><sup>â/+</sup> mice (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>D,E; t<sub>(44)</sub>=1.879, <italic>P</italic>=0.0078). However, <italic>STI1</italic><sup>â/+</sup> mice did not show increased anxiety-like behavior, as determined by the time spent in the center of the box (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>F; <italic>t</italic><sub>(40)</sub>=1.221, <italic>P=</italic>0.341). We also examined another cohort of <italic>STI1</italic><sup>â/+</sup> mice using automated metabolic cages. In this experiment, which mimics the home cage environment, <italic>STI1</italic><sup>â/+</sup> mice again showed hyperactivity during the day and night periods, considering both total activity (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>G; <italic>t</italic><sub>(14)</sub><italic>=</italic>2.558, <italic>P</italic>=0.0228 and <italic>t</italic><sub>(14)</sub><italic>=</italic>2.230, <italic>P</italic>=0.0426) and ambulatory activity (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>H; <italic>t</italic><sub>(14)</sub><italic>=</italic>2.420, <italic>P</italic>=0.00297 and <italic>t</italic><sub>(14)</sub><italic>=</italic>2.230, <italic>P</italic>=0.0426). Given this increased motor activity, <italic>STI1</italic><sup>â/+</sup> mice also demonstrated less sleep time (periods of inactivity) (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>I; <italic>t</italic><sub>(14)</sub>=3949, <italic>P</italic>=0.0015 and <italic>t</italic><sub>(14)</sub>=2.724, <italic>P</italic>=0.0165). Also, <italic>STI1</italic><sup>â/+</sup> mice showed increased consumption of O<sub>2</sub> during the light and dark cycle (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>J; <italic>t</italic><sub>(14)</sub>=2.464, <italic>P</italic>=0.027 and <italic>t</italic><sub>(14)</sub>=2.169, <italic>P</italic>=0.047) and CO<sub>2</sub> production during the dark cycle, but not in the light cycle (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>K; <italic>t</italic><sub>(14)</sub>=2.307, <italic>P</italic>=0.036 and <italic>t</italic><sub>(14)</sub>=1.360, <italic>P</italic>=0.195). No differences were observed in other parameters such as respiratory ratio (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>L; <italic>t</italic><sub>(14)</sub>=0.4455, <italic>P</italic>=0.6627 and <italic>t</italic><sub>(14)</sub>=0.459, <italic>P</italic>=0.653), food consumption (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>M; <italic>t</italic><sub>(14)</sub>=0.5216, <italic>P</italic>=0.6101 and <italic>t</italic><sub>(14)</sub>=0.6134, <italic>P</italic>=0.5494), water consumption (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>N; <italic>t</italic><sub>(14)</sub>=1.801, <italic>P</italic>=0.0933 and <italic>t</italic><sub>(14)</sub>=0.2752, <italic>P</italic>=0.7872), and heat production (<xref ref-type="fig" rid="DMM022525F3">Fig.Â 3</xref>O; <italic>t</italic><sub>(14)</sub>=1.014, <italic>P</italic>=0.3276 and <italic>t</italic><sub>(14)</sub>=0.1935, <italic>P</italic>=0.8494) comparing <italic>STI1</italic><sup>â/+</sup> to <italic>STI1</italic><sup>+/+</sup> mice for both cycles (light and dark).
<fig id="DMM022525F3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p><bold>Locomotor activity in <italic>STI1</italic><sup>TGA</sup> and <italic>STI1</italic><sup>â/+</sup>mice and metabolic analyses in <italic>STI1</italic><sup>â/+</sup>mice.</bold> (A) Horizontal locomotor activity in an open-field for <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=14) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=14). (B) Cumulative 1âh locomotion for <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=14) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=14). (C) Time spent in the center of the locomotion boxes for <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=14) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=14). (D) Horizontal locomotor activity in an open-field for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (E) Cumulative 1âh locomotion for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=22) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=24). (F) Time spent in the center of the locomotion boxes for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=22) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=24). (G) Total activity in metabolic cages for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (H) Ambulatory activity in metabolic cages for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (I) Sleep time for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (J) VO<sub>2</sub> for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (K) VCO<sub>2</sub> for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (L) Respiratory exchange ratio for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (M) Food consumption for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (N) Water consumption for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). (O) Energy expenditure for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=8) and <italic>STI</italic><sup>+/+</sup> control mice (<italic>n</italic>=8). Results are presented as meansÂ±s.e.m.; data were analyzed and compared by Student's <italic>t-</italic>test; *<italic>P</italic>&lt;0.05 compared with control.</p></caption><graphic xlink:href="dmm-8-022525-g3"></graphic></fig></p>
<p>In order to test for other neuropsychiatric-like behaviors as a result of altered STIP1 levels we tested both <italic>STI</italic><sup>TGA</sup> and <italic>STI1</italic><sup>â/+</sup> mice for anxiety-like behavior (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>A-D) and depression-like behavior (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>E,F). Given the hyperactivity of <italic>STI1</italic><sup>â/+</sup> mice, we also decided to investigate whether they had alterations in compulsive-like behavior, assessed by measurement of self-grooming and marble burying (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>G-I). There was no difference in the behavior of either <italic>STI</italic><sup>TGA</sup> (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>A,B,E) or <italic>STI1</italic><sup>â/+</sup> (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>C,D,F-I) mice compared with control mice in all these behavioral tasks: time spent in the open arm (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>C; t<sub>19</sub>=0.310, <italic>P</italic>=0.7590), time spent in the closed arm (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>D; t<sub>(19)</sub>=0.3730, <italic>P</italic>=0.7133), forced swim test (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>F; t<sub>(12)</sub>=1.184, <italic>P</italic>=0.2594), grooming bouts (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>H; t<sub>(20)</sub>=0.7848, <italic>P</italic>=0.4418), time grooming (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>G; t<sub>(20)</sub>=0.6072, <italic>P</italic>=0.5505) and marble burying (<xref ref-type="fig" rid="DMM022525F4">Fig.Â 4</xref>I; t<sub>(21)</sub>=0.4956, <italic>P</italic>=0.6253).
<fig id="DMM022525F4" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p><bold>Anxiety-like behavior, depression-like behavior, social behavior and compulsivity in <italic>STI1</italic><sup>TGA</sup> and <italic>STI1</italic><sup>â/+</sup> mice.</bold> (A) Percentage of time spent in the closed arm for <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=17) and control mice (<italic>n</italic>=14). (B) Percentage of time spent in the open arm for <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=17) and control mice (<italic>n</italic>=14). (C) Percentage of time spent in the closed arm for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=13) and control mice (<italic>n</italic>=10). (D) Percentage of time spent in the open arm for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=13) and control mice (<italic>n</italic>=10). (E) Immobility time in the forced-swimming test for <italic>STI1</italic><sup>TGA</sup> (<italic>n</italic>=17) and control mice (<italic>n</italic>=14). (F) Immobility time in the forced-swimming test for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=6) and control mice (<italic>n</italic>=8). (G,H) Time spent grooming and number of grooming bouts for <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=11) and control mice (<italic>n</italic>=11). (I) Marbles buried by <italic>STI1</italic><sup>â/+</sup> (<italic>n</italic>=12) and control mice (<italic>n</italic>=12).</p></caption><graphic xlink:href="dmm-8-022525-g4"></graphic></fig></p>
<p>Next, we investigated spatial navigation memory in both <italic>Stip1</italic> mutant mice using the Morris water maze (MWM). Neither <italic>STI1</italic><sup>TGA</sup> nor <italic>STI1</italic><sup>â/+</sup> mice presented deficits in acquisition or retrieval of spatial memory in the MWM. For both <italic>STI1</italic><sup>TGA</sup> and <italic>STI1</italic><sup>â/+</sup>, performance during the 4-day acquisition phase was indistinguishable from their wild-type controls in terms of latency to find the target (<xref ref-type="fig" rid="DMM022525F5">Fig.Â 5</xref>A; RM-ANOVA <italic>F</italic><sub>(1,13)</sub>=0.062, <italic>P</italic>=0.806) or speed (<xref ref-type="fig" rid="DMM022525F5">Fig.Â 5</xref>C; <italic>F</italic><sub>(1,10)</sub>=0.215, <italic>P</italic>=0.652). When spatial memory retrieval was performed on the day-5 probe trial, again no differences were observed between <italic>STI1</italic><sup>TGA</sup> and <italic>STI1</italic><sup>â/+</sup> mice, compared with their wild-type controls, for time spent investigating the target quadrant (<xref ref-type="fig" rid="DMM022525F5">Fig.Â 5</xref>D; <italic>F</italic><sub>(1,13)</sub>=1.046, <italic>P</italic>=0.3251) or latency (<xref ref-type="fig" rid="DMM022525F5">Fig.Â 5</xref>E; <italic>F</italic><sub>(1,10)</sub>=0.215, <italic>P</italic>=0.294).
<fig id="DMM022525F5" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p><bold>Spatial memory in <italic>STI1</italic><sup>TGA</sup> and <italic>STI1</italic><sup>â/+</sup> mice.</bold> For the tests, <italic>n</italic>=14 <italic>STI1</italic><sup>+/+</sup> and 14 <italic>STI1</italic><sup>TGA</sup> mice were used to test spatial memory in <italic>STI1</italic><sup>TGA</sup> mice and <italic>n</italic>=11 <italic>STI1</italic><sup>+/+</sup> and 11 <italic>STI1</italic><sup>â/+</sup> for <italic>STI1</italic><sup>â/+</sup> mice. (A) Latency to find the platform. (B) Distance traveled. (C) Speed for <italic>STI1</italic><sup>TGA</sup> mice. (D) Percentage time spent by <italic>STI1</italic><sup>TGA</sup> mice and controls in target quadrant (T) and in opposite (O), right (R) and left (L) quadrants was measured on day 5 in a 60âs probe trial with the platform removed. (E) Latency to find the platform. (F) Distance traveled. (G) Speed for <italic>STI1</italic><sup>â/+</sup> mice. (H) Percentage time spent by <italic>STI1</italic><sup>â/+</sup> mice and controls in each quadrant was measured on day 5 in a 60âs probe trial with the platform removed. Results are presented as meansÂ±s.e.m.; data were analyzed and compared by two-way ANOVA; ***<italic>P</italic>&lt;0.001 and ****<italic>P</italic>&lt;0.0001 compared with time spent in target quadrant.</p></caption><graphic xlink:href="dmm-8-022525-g5"></graphic></fig></p>
<p>Given the hyperactivity phenotype and genetic data suggesting the potential of STIP1 to be linked to ADHD (<xref ref-type="bibr" rid="DMM022525C39">Mick et al., 2011</xref>), a trait commonly found in ASD (<xref ref-type="bibr" rid="DMM022525C23">Gadow et al., 2006</xref>; <xref ref-type="bibr" rid="DMM022525C26">Goldstein and Schwebach, 2004</xref>; <xref ref-type="bibr" rid="DMM022525C31">Lee and Ousley, 2006</xref>; <xref ref-type="bibr" rid="DMM022525C40">Mulligan et al., 2009</xref>), we also determined whether changes in STIP1 levels affected attentional processing. For this, we used the 5-CSRTT. After mice were trained to perform to a criterion (&gt;80% accuracy, &lt;20% omissions) at a 2âs stimulus duration, we assessed attentional performance by using reduced stimulus durations in probe trials (1.5, 1, 0.8 and 0.6âs stimulus durations) as previously described (<xref ref-type="bibr" rid="DMM022525C46">Romberg et al., 2011</xref>). We observed no differences in attentional performance in <italic>STI1</italic><sup>TGA</sup> mice compared with their littermate controls. There was no difference in accuracy (<xref ref-type="fig" rid="DMM022525F6">Fig.Â 6</xref>A; RM-ANOVA showed no effect of genotype <italic>F</italic><sub>(1,20)</sub>=0.0057, <italic>P</italic>=0.9403, main effect of stimulus duration <italic>F</italic><sub>(3,60)</sub>=12.14, <italic>P</italic>&lt;0.0001 and no significant interaction <italic>F</italic><sub>(3,60)</sub>=0.1328, <italic>P</italic>=0.9402) or omission rates (<xref ref-type="fig" rid="DMM022525F6">Fig.Â 6</xref>B; RM-ANOVA showed no effect of genotype <italic>F</italic><sub>(1,18)</sub>=0.2429, <italic>P</italic>=0.6281, main effect of stimulus duration <italic>F</italic><sub>(3,54)</sub>=17.62, <italic>P</italic>&lt;0.0001 and significant interaction <italic>F</italic><sub>(3,54)</sub>=3.854, <italic>P</italic>=0.0143). Post-hoc analysis showed that there was no significant difference between <italic>STI1</italic><sup>TGA</sup> mice and controls. There was also no difference in premature responses, a measure of impulsivity (<xref ref-type="fig" rid="DMM022525F6">Fig.Â 6</xref>C; RM-ANOVA showed no effect of genotype <italic>F</italic><sub>(1,9)</sub>=0.00056, <italic>P</italic>=0.9419, no effect of stimulus duration <italic>F</italic><sub>(3.27)</sub>=0.8254, <italic>P</italic>=0.4914 and no significant interaction <italic>F</italic><sub>(3,27)</sub>=1.109, <italic>P</italic>=0.3625). Moreover, we did not find any difference in motivation, measured as latency to touch the screen (<xref ref-type="fig" rid="DMM022525F6">Fig.Â 6</xref>D; RM-ANOVA showed no effect of genotype <italic>F</italic><sub>(1,9)</sub>=3.399, <italic>P</italic>=0.0983, main effect of stimulus duration <italic>F</italic><sub>(3.30)</sub>=4.281, <italic>P</italic>=0.0125 and no significant interaction <italic>F</italic><sub>(3,30)</sub>=2.332, <italic>P</italic>=0.0941). Compulsivity and motivation were not altered either, as assessed by perseverative responses (<xref ref-type="fig" rid="DMM022525F6">Fig.Â 6</xref>F; RM-ANOVA, showed no effect of genotype <italic>F</italic><sub>(1,9)</sub>=3.974, <italic>P</italic>=0.0774, main effect of stimulus duration <italic>F</italic><sub>(3,27)</sub>=4.808, <italic>P</italic>=0.0083 and no significant interaction <italic>F</italic><sub>(3,27)</sub>=0.1773, <italic>P</italic>=0.9108) and reward collection latency (<xref ref-type="fig" rid="DMM022525F6">Fig.Â 6</xref>E; RM-ANOVA showed no effect of genotype <italic>F</italic><sub>(1,10)</sub>=1.291, <italic>P</italic>=0.2824, no effect of stimulus duration <italic>F</italic><sub>(3,30)</sub>=2.162, <italic>P</italic>=0.1132 and no significant interaction <italic>F</italic><sub>(3.30)</sub>=0.7372, <italic>P</italic>=0.5381).
<fig id="DMM022525F6" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p><bold>Five-choice serial reaction time task used to measure attention in <italic>STI1</italic><sup>TGA</sup> and <italic>STI1</italic><sup>â/+</sup>.</bold> For the tests, <italic>n</italic>=10 <italic>STI1</italic><sup>+/+</sup> and 10 <italic>STI1</italic><sup>TGA</sup> mice were used to test attention in <italic>STI1</italic><sup>TGA</sup> mice and <italic>n</italic>=13 <italic>STI1</italic><sup>+/+</sup> and 13 <italic>STI1</italic><sup>â/+</sup> for <italic>STI1</italic><sup>â/+</sup> mice. (A) Accuracy during probe trial sessions. (B) Rate of omission. (C) Premature responses. (D) Response latency. (E) Reward collection latency. (F) Perseverative responses for <italic>STI1</italic><sup>TGA</sup> mice. (G) Accuracy during probe trial sessions. (H) Rate of omission. (I) Premature responses. (J) Response latency. (K) Reward collection latency. (L) Perseverative response for <italic>STI1</italic><sup>â/+</sup> mice. Results are presented as meansÂ±s.e.m.; data were analyzed and compared by RM-ANOVA; *<italic>P</italic>&lt;0.05, **<italic>P</italic>&lt;0.001 compared with control.</p></caption><graphic xlink:href="dmm-8-022525-g6"></graphic></fig></p>
<p>In contrast, when attentional demand was increased, <italic>STI1</italic><sup>â/+</sup> mice presented decreased accuracy (<xref ref-type="fig" rid="DMM022525F6">Fig.Â 6</xref>G; RM-ANOVA, main effect of genotype <italic>F</italic><sub>(1,25)</sub>=6.872, <italic>P</italic>=0.0147, main effect of stimulus duration <italic>F</italic><sub>(3,75)</sub>=41.95, <italic>P</italic>&lt;0.0001, significant interaction effect <italic>F</italic><sub>(3,75)</sub>=4.170, <italic>P</italic>=0.0087) and increased omission rates (<xref ref-type="fig" rid="DMM022525F6">Fig.Â 6</xref>H; RM-ANOVA, main effect of genotype <italic>F</italic><sub>(1,25)</sub>=6.584, <italic>P</italic>=0.0167, main effect of stimulus duration <italic>F</italic><sub>(3,75)</sub>=24.62, <italic>P</italic>&lt;0.0001, significant interaction effect <italic>F</italic><sub>(3,75)</sub>=3.401, <italic>P</italic>=0.0220). Post-hoc analysis revealed that the <italic>STI1</italic><sup>â/+</sup> mice were significantly impaired in both accuracy and omissions at the 0.6âs stimulus duration. The worse performance of <italic>STI1</italic><sup>â/+</sup> mice was not related to changes in motivation (latency to respond to the stimulus, RM-ANOVA, no effect of genotype <italic>F</italic><sub>(1,25)</sub>=0.01856, <italic>P</italic>=0.8925, no effect of stimulus duration <italic>F</italic><sub>(3,75)</sub>=1.720, <italic>P</italic>=0.1702, no interaction <italic>F</italic><sub>(3,75)</sub>=1.070, <italic>P</italic>=0.3669). There was also no difference in latency to retrieve the reward following a correct response (RM-ANOVA, no effect of genotype <italic>F</italic><sub>(1,25)</sub>=0.03176, <italic>P</italic>=0.8600, no effect of stimulus duration <italic>F</italic><sub>(3,75)</sub>=0.3997, <italic>P</italic>=0.7536, no interaction <italic>F</italic><sub>(3,75)</sub>=1.785, <italic>P</italic>=0.8284). Moreover, we detected no increase in premature responses (RM-ANOVA, no effect of genotype <italic>F</italic><sub>(1,25)</sub>=0.0958, <italic>P</italic>=0.7595, main effect of stimulus duration <italic>F</italic><sub>(3,75)</sub>=2.907, <italic>P</italic>=0.0401, no interaction effect <italic>F</italic><sub>(3,75)</sub>=2.017, <italic>P</italic>=0.1187) or perseverative responses (RM-ANOVA, no effect of genotype <italic>F</italic><sub>(1,25)</sub>=0.04188, <italic>P</italic>=0.8395, main effect of stimulus duration <italic>F</italic><sub>(3,75)</sub>=6.975, <italic>P</italic>=0.0003, no interaction effect <italic>F</italic><sub>(3,75)</sub>=1.139, <italic>P</italic>=0.3389).</p>
</sec>
<sec id="s3" sec-type="discussion">
<title>DISCUSSION</title>
<p>The present experiments tested whether alterations in STIP1 levels have consequences for psychiatric-like behaviors in mice. Our results suggest that decreased, but not increased, STIP1 levels cause significant behavioral alterations in mice. Spatial learning and memory, as well as anxiety and depression-like behavior do not seem to be affected by reduced STIP1 levels. However, mutant mice deficient for STIP1 are hyperactive and present attention deficits.</p>
<p>STIP1 has recently emerged as a protein of potential interest in ASD and endophenotypes related to ASD. Maternal autoantibodies against STIP1 have been identified in mothers of children with ASD (<xref ref-type="bibr" rid="DMM022525C8">Braunschweig et al., 2013</xref>). Moreover, recent global-wide association study (GWAS) analysis identified a polymorphism in <italic>STIP1</italic> (the human gene coding for STIP1/HOP) as a potential risk factor in a population of individuals diagnosed with attention-deficit disorder (<xref ref-type="bibr" rid="DMM022525C39">Mick et al., 2011</xref>), a co-morbidity often associated with ASD (<xref ref-type="bibr" rid="DMM022525C10">Brimberg et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C25">Goldani et al., 2014</xref>). The consequences of this polymorphism for STIP1 expression is unknown, but the presence of autoantibodies against STIP1 might affect expression levels of the protein, given that antibodies can penetrate the blood brain barrier of the fetus during pregnancy (<xref ref-type="bibr" rid="DMM022525C6">Braunschweig et al., 2012a</xref>; <xref ref-type="bibr" rid="DMM022525C17">Diamond et al., 2009</xref>; <xref ref-type="bibr" rid="DMM022525C22">Fox et al., 2012</xref>; <xref ref-type="bibr" rid="DMM022525C54">Zhang et al., 2012</xref>). Indeed, maternal antibodies that recognize STIP1 and other targets when injected in pregnant rodents or developing pups can lead to offspring with abnormal neurons and behaviors that relate to ASD (<xref ref-type="bibr" rid="DMM022525C7">Braunschweig et al., 2012b</xref>; <xref ref-type="bibr" rid="DMM022525C12">Camacho et al., 2014</xref>). To a degree, <italic>STI1</italic><sup>â/+</sup> mice model this early developmental deficit in STIP1 levels. However, in <italic>STI1</italic><sup>â/+</sup> mice STIP1 expression is persistently decreased through life, which could also have important consequences for the phenotypes described.</p>
<p>STIP1 is a modular protein containing several tetratricopeptide (TRP) repeat domains and aspartate-proline (DP) reach domains (<xref ref-type="bibr" rid="DMM022525C50">Taipale et al., 2010</xref>). TRP1 and TRP2B can interact with Hsp70 (<xref ref-type="bibr" rid="DMM022525C21">Flom et al., 2007</xref>; <xref ref-type="bibr" rid="DMM022525C47">Scheufler et al., 2000</xref>), whereas TPR2A is required for interaction with Hsp90 (<xref ref-type="bibr" rid="DMM022525C21">Flom et al., 2007</xref><xref ref-type="bibr" rid="DMM022525C20">, 2006</xref>). Hsp90 activity is regulated by STIP1 and previous work has shown that in mice no other co-chaperone can replace STIP1 (<xref ref-type="bibr" rid="DMM022525C5">Beraldo et al., 2013</xref>). Recent experiments have indicated that the chaperone machinery, activated by the transcription factor heat shock factor 1 (HSF1), is responsible for preventing damaging effects from environmental factors in the developing brain (<xref ref-type="bibr" rid="DMM022525C29">Hashimoto-Torii et al., 2014</xref>). Indeed, the chaperone machinery can buffer many stresses at the cellular level and, therefore, it is not surprising that functional changes in its components have physiological consequences.</p>
<p>In addition to its intracellular chaperone function, STIP1 is also secreted by a myriad of cells, including astrocytes via an extracellular vesicle population, which includes exosomes (<xref ref-type="bibr" rid="DMM022525C28">Hajj et al., 2013</xref>). Extracellular STIP1 also mediates important physiological responses in the brain. Acting as a trophic factor to engage PrP<sup>C</sup> to signal in neurons, it regulates neuritogenesis and neuronal survival (<xref ref-type="bibr" rid="DMM022525C4">Beraldo et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022525C34">Lopes et al., 2005</xref>; <xref ref-type="bibr" rid="DMM022525C45">Roffe et al., 2010</xref>). STIP1 has a role in functional recovery in stroke (<xref ref-type="bibr" rid="DMM022525C5">Beraldo et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C32">Lee et al., 2013</xref>). Moreover, STIP1 also modulates toxicity of AÎ² peptides in models of Alzheimer's disease (<xref ref-type="bibr" rid="DMM022525C9">Brehme et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022525C43">Ostapchenko et al., 2013</xref>).</p>
<p>It is remarkable that mice with increased levels of STIP1 (up to almost fivefold) do not present any major behavioral alteration. In the extensive evaluation of cognitive phenotypes in this study, which included anxiety and depression-like behaviors, spatial memory and attention, we showed that <italic>STI1</italic><sup>TGA</sup> mice perform as well as littermate controls. These results suggest that strategies to increase STIP1 levels should not cause toxicity with consequences for brain functions. This is important, given that increased STIP1 levels might be protective against insults such as stroke-mediated cell death and in Alzheimer's disease (<xref ref-type="bibr" rid="DMM022525C5">Beraldo et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C43">Ostapchenko et al., 2013</xref>). Interestingly, whereas increased levels of STIP1 seem to affect the chaperone machinery, prion protein expression is not affected by decreasing the level of Hsp70 and increasing Hsp90. These consequences of increased STIP1 seem to occur at the post-translational level, given that mRNAs for Hsp70 and 90 were not affected. It is unknown at the moment whether increased STIP1 levels stabilize a complex containing Hsp90, preferentially leading to increased turnover of Hsp70.</p>
<p>At present, the exact mechanism by which decreased STIP1 levels affect psychiatric-like behavior is still unknown. Although it is possible that decreased levels of STIP1 during early development have persistent effects in brain circuits, culminating with hyperactivity and attentional deficits, we cannot discard the possibility that STIP1 plays a role in regulating circuitry function in the adult brain. Our experiments at the moment do not discriminate whether the phenotypes observed in mutant mice result from decreased STIP1co-chaperone function, diminished STIP1 extracellular signaling or both. Our results suggest that reduced levels of STIP1 have important consequences for behavior and seem to affect brain circuits that regulate attention. It is possible that exposure to STIP1 antibodies during pregnancy could reduce STIP1 levels, which, based on the present results, would have important consequences. Future experiments are required to define potential mechanisms as well as the consequences of disturbed STIP1 activity in ASD.</p>
</sec>
<sec id="s4" sec-type="methods">
<title>MATERIALS AND METHODS</title>
<sec id="s4a">
<title>Animals</title>
<p><italic>STI1</italic><sup>â/+</sup> and <italic>STI1</italic><sup>TGA</sup> mice were generated as described (<xref ref-type="bibr" rid="DMM022525C5">Beraldo et al., 2013</xref>). Both mouse lines were in the C57BL/6J background. All experimental procedures were conducted in compliance with the Canadian Council of Animal Care guidelines for use and care of animals and in accordance with approved animal use protocols at the University of Western Ontario (2008/127). Animals were housed in groups of two or four per cage. Mice were kept in a temperature-controlled room with a 12/12 light/dark cycle (7 am/7 pm) with food and water provided <italic>ad libitum</italic> unless stated otherwise. For behavioral studies, only male mice were used. Mice were randomized and the experimenter was blind to genotypes. For most of the behavioral tasks, software-based analyses were used to score mice performance with minimum human interference.</p>
</sec>
<sec id="s4b">
<title>qPCR and Western blot</title>
<p>For real-time quantitative PCR (qPCR), brain tissues were homogenized in Trizol and total RNA was extracted using the Aurum Total RNA kit for fatty and fibrous tissue (Bio-Rad, Hercules, CA, USA). qPCR were performed as previously described (<xref ref-type="bibr" rid="DMM022525C36">Martins-Silva et al., 2011</xref>). Primer sequences: STIP1-F, 5â²-GCCAAGAAAGGAGACTACCAG-3â²; STIP1-R, 5â²-TCATAGGTTCGTTTGGCTTCC-3â²; HsP90-F, 5â²-CCACCCTGCTCTGTACTACT-3â²; HsP90-R, 5â²-CCAGGGCATCTGAAGCATTA-3â²; HsP70-R, 5â²-ACCTTGACAGTAATCGGTGC-3â²; HsP70-F, 5â²-CTCCCGGTGTGGTCTAGAAA-3â²; PRP-F, 5â²-GAACCATTTCAACCGAGCTG-3â²; PRP-R, 5â²-CATAGTCACAAAGAGGGCCAG-3â²; Actin-F, 5â²-TGGAATCCTGTGGCATCCATGA-3â²; and Actin-R, 5â²-AATGCCTGGGTACATGGTGGTA-3â². Immunoblot analysis was carried out as described previously (<xref ref-type="bibr" rid="DMM022525C5">Beraldo et al., 2013</xref>). The antibodies used were anti-STIP1 (1:5000, in-house antibody generated by Bethyl Laboratories Montgomery, USA using recombinant STIP1) (<xref ref-type="bibr" rid="DMM022525C5">Beraldo et al., 2013</xref>), anti-Hsp90 (1:1000), anti-Hsp70 (1:1000), anti-Hsp90Î± (1:1000), anti Hsp90Î² (1:1000) (Cell Signaling, Danvers, USA) and anti-PrP 8H4 (1:2000) (Abcam, Cambrige, UK).</p>
</sec>
<sec id="s4c">
<title>Locomotor activity</title>
<p>Mice were acclimated to the testing room for 30âmin prior to beginning the test; locomotor activity was automatically recorded (Omnitech Electronics Inc., Columbus, USA). Mice were placed in the center of the apparatus and locomotor activity was measured at 5âmin intervals for 1âh as described previously (<xref ref-type="bibr" rid="DMM022525C37">Martyn et al., 2012</xref>).</p>
</sec>
<sec id="s4d">
<title>Elevated plus maze</title>
<p>To access anxiety-like behavior, mice were acclimated to the testing room for 30âmin prior to beginning the test and then placed in the center of the elevated plus maze (Med Associates Inc., St Albans, USA). The activity was recorded and videos were analyzed using ANY-maze software (Stoelting Co., USA) to determine the amount of time spent in the closed and open sections of the maze.</p>
</sec>
<sec id="s4e">
<title>Forced swimming test</title>
<p>Depressive-like behavior was assessed by a forced swim test (FST) as described previously (<xref ref-type="bibr" rid="DMM022525C37">Martyn et al., 2012</xref>). Briefly, mice were placed in a 2âl beaker containing 1.7âl of water at 25-27Â°C for 6âmin. Experimental sessions were recorded and immobility time was evaluated using ANY-Maze Software (Stoelting Co., USA). Data obtained from the last 4âmin of testing were used for the analysis.</p>
</sec>
<sec id="s4f">
<title>Morris water maze</title>
<p>The spatial version of Morris water maze (MWM) was conducted as described previously (<xref ref-type="bibr" rid="DMM022525C30">Kolisnyk et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C37">Martyn et al., 2012</xref>; <xref ref-type="bibr" rid="DMM022525C52">Vorhees and Williams, 2006</xref>). Briefly, the task was performed in a 1.5-m diameter/1-m deep pool filled with water at 25Â°C. Spatial cues, 40Ã40âcm boards containing black symbols (vertical and horizontal stripes, triangles, squares and circles), were placed on the walls distributed around the pool and the platform was submerged 1âcm below the surface of the water. Mice were submitted to four training trials a day (90âs each) for four consecutive days with a 15âmin intertrial interval. On day 5, memory was assessed by a single 60âs trial on which the platform was removed and the time spent in the target quadrant was evaluated. All the experimental sessions were recorded and analyzed using the ANY-Maze Software.</p>
</sec>
<sec id="s4g">
<title>Five-choice serial reaction time task</title>
<p>The five-choice serial reaction time task (5-CSRTT) was used to evaluate attention in mice as described previously (<xref ref-type="bibr" rid="DMM022525C30">Kolisnyk et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C46">Romberg et al., 2011</xref>). Mice were trained in the 5-CSRTT in automated BusseyâSaksidaTouch screen systems (Campden Instruments Limited, Loughborough, EN) and the data collected using ABET II Touch software V.2.18 (Lafayette Instruments, Lafayette, USA). Mice were submitted to a pre-training program, which consisted of first habituating the mouse to the testing chamber with the lights off for 10âmin. The next day, the mouse was put in the chamber with the lights off for 20âmin. After two days of habituation with no reward been offered, the reward tray was primed with 11% fat strawberry milkshake (Nielson - Saputo Dairy Products) and a tone was played when the mouse entered the reward tray. This was repeated for the next 2âdays for 40âmin sessions. Whenever the mouse returned to the reward tray, the reward was offered and paired with a tone (phase I). The following training phase consisted in pairing the reward with the presentation of a random stimulus (flash of light in one of the five windows), which is removed after 30âs. At this phase, if the mouse touched the screen when the stimulus was displayed, it received a reward. This cycle was repeated until the mouse completed 30 trials or 60âmin timeout (phase II). At phase III of the training, the stimulus was displayed randomly in one of the five windows. The mouse had to touch the window where the stimulus was displayed to receive the reward paired with a tone. Similar to phase II, this cycle was repeated until the mouse completed 30 trials or 60âmin timeout. The next step (phase IV) was identical to phase III except by the fact that the mouse had to poke its nose into the reward trail to initiate the task. This process was repeated in the last phase of the pre-training (phase V); however, if the mouse touched an incorrect screen, it received a 5âs timeout and the light in the chamber was turned on. After the mouse had finished pre-training and reached criterion at 4âs and 2âs stimulus duration (80% accuracy, 20% omission for three consecutive days), mice were probed for attention deficits following probe trial schedules: each mouse was tested over two sessions at 1.5, 1.0, 0.8 and 0.6âs stimulus duration (the order of the probe trial sessions was randomized and the groups counterbalanced). Between each different stimulus duration, each mouse was returned to a 2âs stimulus for two consecutive sessions. Number of trials to criterion, accuracy, omission, reward collection latency and perseverative response were analyzed.</p>
</sec>
<sec id="s4h">
<title>Metabolic assessments</title>
<p>Oxygen consumption, carbon dioxide production, respiratory exchange ratio (RER), carbon dioxide production, water and food intake and physical activity were simultaneously measured for adult <italic>STI1</italic><sup>+/+</sup> and <italic>STI1</italic><sup>+/â</sup> mice by using the Comprehensive Lab Animal Monitoring System (CLAMS) interfaced with Oxymax Software (Columbus Instruments, Columbus, OH, USA) as previously described in detail (<xref ref-type="bibr" rid="DMM022525C27">Guzman et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022525C30">Kolisnyk et al., 2013</xref>). Briefly, mice were individually housed in the metabolic chambers with <italic>ad libitum</italic> access to water and food. Following a 16-h habituation period, all measurements were obtained every 10âmin for 24âh (12âh light/12âh dark).</p>
</sec>
<sec id="s4i">
<title>Marble burying task</title>
<p>A marble burying task was used to assess repetitive and anxiety-like behavior as previously described (<xref ref-type="bibr" rid="DMM022525C16">Deacon, 2006</xref>).</p>
</sec>
<sec id="s4j">
<title>Assessment of self-grooming</title>
<p>Self-grooming was assessed to evaluate repetitive behavior, as previously described (<xref ref-type="bibr" rid="DMM022525C38">McFarlane et al., 2008</xref>). Briefly, each mouse was placed individually in a clean, empty, cage and given a 10âmin habituation period, after which the mice were filmed for another 10âmin. Cumulative time spent grooming and number of grooming bouts were counted by an experimenter blinded to the genotypes of the mice.</p>
</sec>
<sec id="s4k">
<title>Statistical analyses</title>
<p>Data are presented as meanÂ±s.e.m. Statistical analyses were performed using SigmaStat 3.5 software. Student's <italic>t</italic>-test was used to compare two experimental groups and for comparison of several experimental groups, two-way ANOVA or two-way repeated-measures ANOVA were used as required. Tukey's post hoc comparison was used when required.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<title>Footnotes</title>
<fn fn-type="conflict">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare no competing or financial interests.</p>
</fn>
<fn>
<p>
<bold>Author contributions</bold>
</p>
<p>F.H.B., M.A.M.P., V.F.P., and R.G. conceived and designed experiments. F.H.B., A.T., B.K., P.H.H., R.G., X.D.J., A.C.M., J.F., D.F.G., M.F.C. and T.M. performed the experiments. V.R.M. contributed with specific reagents. F.H.B., A.T., B.K., A.C.M., V.F.P., R.G., V.R.M. and M.A.M.P. analyzed the data. F.H.B., V.F.P. and M.A.M.P. wrote the paper.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>
<bold>Funding</bold>
</p>
<p>This work was supported by the Canadian Institute of Health Research (MOP 136930, MOP 126000 and MOP 89919; M.A.M.P. and V.F.P.), Canadian Foundation for Innovation (M.A.M.P., V.F.P. and R.G.) and FundaÃ§Ã£o de Amparo a Pesquisa do Estado de SÃ£o Paulo, Brazil (FAPESP-2009/14027-2; V.R.M.).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="DMM022525C1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbas-Terki</surname><given-names>T.</given-names></name>, <name><surname>Briand</surname><given-names>P.-A.</given-names></name>, <name><surname>Donze</surname><given-names>O.</given-names></name> and <name><surname>Picard</surname><given-names>D.</given-names></name></person-group> (<year>2002</year>). <article-title>The Hsp90 co-chaperones Cdc37 and Sti1 interact physically and genetically</article-title>. <source/><italic>Biol. Chem.</italic>
<volume>383</volume>, <fpage>1335</fpage>-<lpage>1342</lpage>. <pub-id pub-id-type="doi">10.1515/BC.2002.152</pub-id><pub-id pub-id-type="pmid">12437126</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauman</surname><given-names>M. D.</given-names></name>, <name><surname>Iosif</surname><given-names>A.-M.</given-names></name>, <name><surname>Ashwood</surname><given-names>P.</given-names></name>, <name><surname>Braunschweig</surname><given-names>D.</given-names></name>, <name><surname>Lee</surname><given-names>A.</given-names></name>, <name><surname>Schumann</surname><given-names>C. M.</given-names></name>, <name><surname>Van de Water</surname><given-names>J.</given-names></name> and <name><surname>Amaral</surname><given-names>D. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey</article-title>. <source/><italic>Transl. Psychiatry</italic>
<volume>3</volume>, <fpage>e278</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.47</pub-id><pub-id pub-id-type="pmid">23838889</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beraldo</surname><given-names>F. H.</given-names></name>, <name><surname>Arantes</surname><given-names>C. P.</given-names></name>, <name><surname>Santos</surname><given-names>T. G.</given-names></name>, <name><surname>Queiroz</surname><given-names>N. G. T.</given-names></name>, <name><surname>Young</surname><given-names>K.</given-names></name>, <name><surname>Rylett</surname><given-names>R. J.</given-names></name>, <name><surname>Markus</surname><given-names>R. P.</given-names></name>, <name><surname>Prado</surname><given-names>M. A. M.</given-names></name> and <name><surname>Martins</surname><given-names>V. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>285</volume>, <fpage>36542</fpage>-<lpage>36550</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.157263</pub-id><pub-id pub-id-type="pmid">20837487</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beraldo</surname><given-names>F. H.</given-names></name>, <name><surname>Soares</surname><given-names>I. N.</given-names></name>, <name><surname>Goncalves</surname><given-names>D. F.</given-names></name>, <name><surname>Fan</surname><given-names>J.</given-names></name>, <name><surname>Thomas</surname><given-names>A. A.</given-names></name>, <name><surname>Santos</surname><given-names>T. G.</given-names></name>, <name><surname>Mohammad</surname><given-names>A. H.</given-names></name>, <name><surname>Roffe</surname><given-names>M.</given-names></name>, <name><surname>Calder</surname><given-names>M. D.</given-names></name>, <name><surname>Nikolova</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Stress-inducible phosphoprotein 1 has unique cochaperone activity during development and regulates cellular response to ischemia via the prion protein</article-title>. <source/><italic>FASEB J.</italic>
<volume>27</volume>, <fpage>3594</fpage>-<lpage>3607</lpage>. <pub-id pub-id-type="doi">10.1096/fj.13-232280</pub-id><pub-id pub-id-type="pmid">23729591</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunschweig</surname><given-names>D.</given-names></name>, <name><surname>Duncanson</surname><given-names>P.</given-names></name>, <name><surname>Boyce</surname><given-names>R.</given-names></name>, <name><surname>Hansen</surname><given-names>R.</given-names></name>, <name><surname>Ashwood</surname><given-names>P.</given-names></name>, <name><surname>Pessah</surname><given-names>I. N.</given-names></name>, <name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name> and <name><surname>Van de Water</surname><given-names>J.</given-names></name></person-group> (<year>2012a</year>). <article-title>Behavioral correlates of maternal antibody status among children with autism</article-title>. <source/><italic>J. Autism Dev. Disord.</italic>
<volume>42</volume>, <fpage>1435</fpage>-<lpage>1445</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-011-1378-7</pub-id><pub-id pub-id-type="pmid">22012245</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunschweig</surname><given-names>D.</given-names></name>, <name><surname>Golub</surname><given-names>M. S.</given-names></name>, <name><surname>Koenig</surname><given-names>C. M.</given-names></name>, <name><surname>Qi</surname><given-names>L.</given-names></name>, <name><surname>Pessah</surname><given-names>I. N.</given-names></name>, <name><surname>Van de Water</surname><given-names>J.</given-names></name> and <name><surname>Berman</surname><given-names>R. F.</given-names></name></person-group> (<year>2012b</year>). <article-title>Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model</article-title>. <source/><italic>J. Neuroimmunol.</italic>
<volume>252</volume>, <fpage>56</fpage>-<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2012.08.002</pub-id><pub-id pub-id-type="pmid">22951357</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunschweig</surname><given-names>D.</given-names></name>, <name><surname>Krakowiak</surname><given-names>P.</given-names></name>, <name><surname>Duncanson</surname><given-names>P.</given-names></name>, <name><surname>Boyce</surname><given-names>R.</given-names></name>, <name><surname>Hansen</surname><given-names>R. L.</given-names></name>, <name><surname>Ashwood</surname><given-names>P.</given-names></name>, <name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name>, <name><surname>Pessah</surname><given-names>I. N.</given-names></name> and <name><surname>Van de Water</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Autism-specific maternal autoantibodies recognize critical proteins in developing brain</article-title>. <source/><italic>Transl. Psychiatry</italic>
<volume>3</volume>, <fpage>e277</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.50</pub-id><pub-id pub-id-type="pmid">23838888</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brehme</surname><given-names>M.</given-names></name>, <name><surname>Voisine</surname><given-names>C.</given-names></name>, <name><surname>Rolland</surname><given-names>T.</given-names></name>, <name><surname>Wachi</surname><given-names>S.</given-names></name>, <name><surname>Soper</surname><given-names>J. H.</given-names></name>, <name><surname>Zhu</surname><given-names>Y.</given-names></name>, <name><surname>Orton</surname><given-names>K.</given-names></name>, <name><surname>Villella</surname><given-names>A.</given-names></name>, <name><surname>Garza</surname><given-names>D.</given-names></name>, <name><surname>Vidal</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease</article-title>. <source/><italic>Cell Rep.</italic>
<volume>9</volume>, <fpage>1135</fpage>-<lpage>1150</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.09.042</pub-id><pub-id pub-id-type="pmid">25437566</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brimberg</surname><given-names>L.</given-names></name>, <name><surname>Sadiq</surname><given-names>A.</given-names></name>, <name><surname>Gregersen</surname><given-names>P. K.</given-names></name> and <name><surname>Diamond</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder</article-title>. <source/><italic>Mol. Psychiatry</italic>
<volume>18</volume>, <fpage>1171</fpage>-<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.101</pub-id><pub-id pub-id-type="pmid">23958959</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caetano</surname><given-names>F. A.</given-names></name>, <name><surname>Lopes</surname><given-names>M. H.</given-names></name>, <name><surname>Hajj</surname><given-names>G. N. M.</given-names></name>, <name><surname>Machado</surname><given-names>C. F.</given-names></name>, <name><surname>Pinto Arantes</surname><given-names>C.</given-names></name>, <name><surname>Magalhaes</surname><given-names>A. C.</given-names></name>, <name><surname>Vieira</surname><given-names>M. d. P. B.</given-names></name>, <name><surname>Americo</surname><given-names>T. A.</given-names></name>, <name><surname>Massensini</surname><given-names>A. R.</given-names></name>, <name><surname>Priola</surname><given-names>S. A.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>28</volume>, <fpage>6691</fpage>-<lpage>6702</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1701-08.2008</pub-id><pub-id pub-id-type="pmid">18579743</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camacho</surname><given-names>J.</given-names></name>, <name><surname>Jones</surname><given-names>K.</given-names></name>, <name><surname>Miller</surname><given-names>E.</given-names></name>, <name><surname>Ariza</surname><given-names>J.</given-names></name>, <name><surname>Noctor</surname><given-names>S.</given-names></name>, <name><surname>Van de Water</surname><given-names>J.</given-names></name> and <name><surname>Martinez-Cerdeno</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>Embryonic intraventricular exposure to autism-specific maternal autoantibodies produces alterations in autistic-like stereotypical behaviors in offspring mice</article-title>. <source/><italic>Behav. Brain Res.</italic>
<volume>266</volume>, <fpage>46</fpage>-<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.02.045</pub-id><pub-id pub-id-type="pmid">24613242</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name>, <name><surname>Prapapanich</surname><given-names>V.</given-names></name>, <name><surname>Rimerman</surname><given-names>R. A.</given-names></name>, <name><surname>Honore</surname><given-names>B.</given-names></name> and <name><surname>Smith</surname><given-names>D. F.</given-names></name></person-group> (<year>1996</year>). <article-title>Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70</article-title>. <source/><italic>Mol. Endocrinol.</italic>
<volume>10</volume>, <fpage>682</fpage>-<lpage>693</lpage>.<pub-id pub-id-type="pmid">8776728</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name>, <name><surname>Zhao</surname><given-names>C.</given-names></name>, <name><surname>Li</surname><given-names>X.</given-names></name>, <name><surname>Wang</surname><given-names>T.</given-names></name>, <name><surname>Li</surname><given-names>Y.</given-names></name>, <name><surname>Cao</surname><given-names>C.</given-names></name>, <name><surname>Ding</surname><given-names>Y.</given-names></name>, <name><surname>Dong</surname><given-names>M.</given-names></name>, <name><surname>Finci</surname><given-names>L.</given-names></name>, <name><surname>Wang</surname><given-names>J.-H.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Terazosin activates Pgk1 and Hsp90 to promote stress resistance</article-title>. <source/><italic>Nat. Chem. Biol.</italic>
<volume>11</volume>, <fpage>19</fpage>-<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1657</pub-id><pub-id pub-id-type="pmid">25383758</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>P.</given-names></name>, <name><surname>Deacon</surname><given-names>R.</given-names></name>, <name><surname>Blamire</surname><given-names>A.</given-names></name>, <name><surname>Pike</surname><given-names>M.</given-names></name>, <name><surname>McKinlay</surname><given-names>I.</given-names></name>, <name><surname>Stein</surname><given-names>J.</given-names></name>, <name><surname>Styles</surname><given-names>P.</given-names></name> and <name><surname>Vincent</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Maternal neuronal antibodies associated with autism and a language disorder</article-title>. <source/><italic>Ann. Neurol.</italic>
<volume>53</volume>, <fpage>533</fpage>-<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10557</pub-id><pub-id pub-id-type="pmid">12666123</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname><given-names>R. M. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Digging and marble burying in mice: simple methods for in vivo identification of biological impacts</article-title>. <source/><italic>Nat. Protoc.</italic>
<volume>1</volume>, <fpage>122</fpage>-<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.20</pub-id><pub-id pub-id-type="pmid">17406223</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>B.</given-names></name>, <name><surname>Huerta</surname><given-names>P. T.</given-names></name>, <name><surname>Mina-Osorio</surname><given-names>P.</given-names></name>, <name><surname>Kowal</surname><given-names>C.</given-names></name> and <name><surname>Volpe</surname><given-names>B. T.</given-names></name></person-group> (<year>2009</year>). <article-title>Losing your nerves? Maybe it's the antibodies</article-title>. <source/><italic>Nat. Rev. Immunol.</italic>
<volume>9</volume>, <fpage>449</fpage>-<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1038/nri2529</pub-id><pub-id pub-id-type="pmid">19424277</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erlich</surname><given-names>R. B.</given-names></name>, <name><surname>Kahn</surname><given-names>S. A.</given-names></name>, <name><surname>Lima</surname><given-names>F. R. S.</given-names></name>, <name><surname>Muras</surname><given-names>A. G.</given-names></name>, <name><surname>Martins</surname><given-names>R. A. P.</given-names></name>, <name><surname>Linden</surname><given-names>R.</given-names></name>, <name><surname>Chiarini</surname><given-names>L. B.</given-names></name>, <name><surname>Martins</surname><given-names>V. R.</given-names></name> and <name><surname>Moura Neto</surname><given-names>V.</given-names></name></person-group> (<year>2007</year>). <article-title>STI1 promotes glioma proliferation through MAPK and PI3K pathways</article-title>. <source/><italic>Glia</italic>
<volume>55</volume>, <fpage>1690</fpage>-<lpage>1698</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20579</pub-id><pub-id pub-id-type="pmid">17886292</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eustace</surname><given-names>B. K.</given-names></name> and <name><surname>Jay</surname><given-names>D. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Extracellular roles for the molecular chaperone, hsp90</article-title>. <source/><italic>Cell Cycle</italic>
<volume>3</volume>, <fpage>1096</fpage>-<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.4161/cc.3.9.1088</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flom</surname><given-names>G.</given-names></name>, <name><surname>Weekes</surname><given-names>J.</given-names></name>, <name><surname>Williams</surname><given-names>J. J.</given-names></name> and <name><surname>Johnson</surname><given-names>J. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Effect of mutation of the tetratricopeptide repeat and asparatate-proline 2 domains of Sti1 on Hsp90 signaling and interaction in Saccharomyces cerevisiae</article-title>. <source/><italic>Genetics</italic>
<volume>172</volume>, <fpage>41</fpage>-<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.105.045815</pub-id><pub-id pub-id-type="pmid">16219779</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flom</surname><given-names>G.</given-names></name>, <name><surname>Behal</surname><given-names>R. H.</given-names></name>, <name><surname>Rosen</surname><given-names>L.</given-names></name>, <name><surname>Cole</surname><given-names>D. G.</given-names></name> and <name><surname>Johnson</surname><given-names>J. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Definition of the minimal fragments of Sti1 required for dimerization, interaction with Hsp70 and Hsp90 and in vivo functions</article-title>. <source/><italic>Biochem. J.</italic>
<volume>404</volume>, <fpage>159</fpage>-<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20070084</pub-id><pub-id pub-id-type="pmid">17300223</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>E.</given-names></name>, <name><surname>Amaral</surname><given-names>D.</given-names></name> and <name><surname>Van de Water</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Maternal and fetal antibrain antibodies in development and disease</article-title>. <source/><italic>Dev. Neurobiol.</italic>
<volume>72</volume>, <fpage>1327</fpage>-<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22052</pub-id><pub-id pub-id-type="pmid">22911883</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadow</surname><given-names>K. D.</given-names></name>, <name><surname>DeVincent</surname><given-names>C. J.</given-names></name> and <name><surname>Pomeroy</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>ADHD symptom subtypes in children with pervasive developmental disorder</article-title>. <source/><italic>J. Autism Dev. Disord.</italic>
<volume>36</volume>, <fpage>271</fpage>-<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-005-0060-3</pub-id><pub-id pub-id-type="pmid">16477513</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldani</surname><given-names>A. A. S.</given-names></name>, <name><surname>Downs</surname><given-names>S. R.</given-names></name>, <name><surname>Widjaja</surname><given-names>F.</given-names></name>, <name><surname>Lawton</surname><given-names>B.</given-names></name> and <name><surname>Hendren</surname><given-names>R. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Biomarkers in autism</article-title>. <source/><italic>Front. Psychiatry</italic>
<volume>5</volume>, <fpage>100</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2014.00100</pub-id><pub-id pub-id-type="pmid">25161627</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>S.</given-names></name> and <name><surname>Schwebach</surname><given-names>A. J.</given-names></name></person-group> (<year>2004</year>). <article-title>The comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: results of a retrospective chart review</article-title>. <source/><italic>J. Autism Dev. Disord.</italic>
<volume>34</volume>, <fpage>329</fpage>-<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1023/B:JADD.0000029554.46570.68</pub-id><pub-id pub-id-type="pmid">15264500</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>M. S.</given-names></name>, <name><surname>De Jaeger</surname><given-names>X.</given-names></name>, <name><surname>Drangova</surname><given-names>M.</given-names></name>, <name><surname>Prado</surname><given-names>M. A. M.</given-names></name>, <name><surname>Gros</surname><given-names>R.</given-names></name> and <name><surname>Prado</surname><given-names>V. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Mice with selective elimination of striatal acetylcholine release are lean, show altered energy homeostasis and changed sleep/wake cycle</article-title>. <source/><italic>J. Neurochem.</italic>
<volume>124</volume>, <fpage>658</fpage>-<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12128</pub-id><pub-id pub-id-type="pmid">23240572</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajj</surname><given-names>G. N. M.</given-names></name>, <name><surname>Arantes</surname><given-names>C. P.</given-names></name>, <name><surname>Dias</surname><given-names>M. V. S.</given-names></name>, <name><surname>Roffe</surname><given-names>M.</given-names></name>, <name><surname>Costa-Silva</surname><given-names>B.</given-names></name>, <name><surname>Lopes</surname><given-names>M. H.</given-names></name>, <name><surname>Porto-Carreiro</surname><given-names>I.</given-names></name>, <name><surname>Rabachini</surname><given-names>T.</given-names></name>, <name><surname>Lima</surname><given-names>F. R.</given-names></name>, <name><surname>Beraldo</surname><given-names>F. H.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>The unconventional secretion of stress-inducible protein 1 by a heterogeneous population of extracellular vesicles</article-title>. <source/><italic>Cell. Mol. Life Sci.</italic>
<volume>70</volume>, <fpage>3211</fpage>-<lpage>3227</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-013-1328-y</pub-id><pub-id pub-id-type="pmid">23543276</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto-Torii</surname><given-names>K.</given-names></name>, <name><surname>Torii</surname><given-names>M.</given-names></name>, <name><surname>Fujimoto</surname><given-names>M.</given-names></name>, <name><surname>Nakai</surname><given-names>A.</given-names></name>, <name><surname>El Fatimy</surname><given-names>R.</given-names></name>, <name><surname>Mezger</surname><given-names>V.</given-names></name>, <name><surname>Ju</surname><given-names>M. J.</given-names></name>, <name><surname>Ishii</surname><given-names>S.</given-names></name>, <name><surname>Chao</surname><given-names>S.-H.</given-names></name>, <name><surname>Brennand</surname><given-names>K. J.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders</article-title>. <source/><italic>Neuron</italic>
<volume>82</volume>, <fpage>560</fpage>-<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.03.002</pub-id><pub-id pub-id-type="pmid">24726381</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolisnyk</surname><given-names>B.</given-names></name>, <name><surname>Guzman</surname><given-names>M. S.</given-names></name>, <name><surname>Raulic</surname><given-names>S.</given-names></name>, <name><surname>Fan</surname><given-names>J.</given-names></name>, <name><surname>Magalhaes</surname><given-names>A. C.</given-names></name>, <name><surname>Feng</surname><given-names>G.</given-names></name>, <name><surname>Gros</surname><given-names>R.</given-names></name>, <name><surname>Prado</surname><given-names>V. F.</given-names></name> and <name><surname>Prado</surname><given-names>M. A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>ChAT-ChR2-EYFP mice have enhanced motor endurance but show deficits in attention and several additional cognitive domains</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>33</volume>, <fpage>10427</fpage>-<lpage>10438</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0395-13.2013</pub-id><pub-id pub-id-type="pmid">23785154</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D. O.</given-names></name> and <name><surname>Ousley</surname><given-names>O. Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders</article-title>. <source/><italic>J. Child Adolesc. Psychopharmacol.</italic>
<volume>16</volume>, <fpage>737</fpage>-<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1089/cap.2006.16.737</pub-id><pub-id pub-id-type="pmid">17201617</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.-D.</given-names></name>, <name><surname>Lai</surname><given-names>T. W.</given-names></name>, <name><surname>Lin</surname><given-names>S.-Z.</given-names></name>, <name><surname>Lin</surname><given-names>C.-H.</given-names></name>, <name><surname>Hsu</surname><given-names>Y.-H.</given-names></name>, <name><surname>Li</surname><given-names>C.-Y.</given-names></name>, <name><surname>Wang</surname><given-names>H.-J.</given-names></name>, <name><surname>Lee</surname><given-names>W.</given-names></name>, <name><surname>Su</surname><given-names>C.-Y.</given-names></name>, <name><surname>Yu</surname><given-names>Y.-L.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Role of stress-inducible protein-1 in recruitment of bone marrow derived cells into the ischemic brains</article-title>. <source/><italic>EMBO Mol. Med.</italic>
<volume>5</volume>, <fpage>1227</fpage>-<lpage>1246</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201202258</pub-id><pub-id pub-id-type="pmid">23836498</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>F. R. S.</given-names></name>, <name><surname>Arantes</surname><given-names>C. P.</given-names></name>, <name><surname>Muras</surname><given-names>A. G.</given-names></name>, <name><surname>Nomizo</surname><given-names>R.</given-names></name>, <name><surname>Brentani</surname><given-names>R. R.</given-names></name> and <name><surname>Martins</surname><given-names>V. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation</article-title>. <source/><italic>J. Neurochem.</italic>
<volume>103</volume>, <fpage>2164</fpage>-<lpage>2176</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04904.x</pub-id><pub-id pub-id-type="pmid">17868300</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>M. H.</given-names></name>, <name><surname>Hajj</surname><given-names>G. N. M.</given-names></name>, <name><surname>Muras</surname><given-names>A. G.</given-names></name>, <name><surname>Mancini</surname><given-names>G. L.</given-names></name>, <name><surname>Castro</surname><given-names>R. M. P. S.</given-names></name>, <name><surname>Ribeiro</surname><given-names>K. C. B.</given-names></name>, <name><surname>Brentani</surname><given-names>R. R.</given-names></name>, <name><surname>Linden</surname><given-names>R.</given-names></name> and <name><surname>Martins</surname><given-names>V. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>25</volume>, <fpage>11330</fpage>-<lpage>11339</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2313-05.2005</pub-id><pub-id pub-id-type="pmid">16339028</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Cerdeno</surname><given-names>V.</given-names></name>, <name><surname>Camacho</surname><given-names>J.</given-names></name>, <name><surname>Fox</surname><given-names>E.</given-names></name>, <name><surname>Miller</surname><given-names>E.</given-names></name>, <name><surname>Ariza</surname><given-names>J.</given-names></name>, <name><surname>Kienzle</surname><given-names>D.</given-names></name>, <name><surname>Plank</surname><given-names>K.</given-names></name>, <name><surname>Noctor</surname><given-names>S. C.</given-names></name> and <name><surname>Van de Water</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Prenatal exposure to autism-specific maternal autoantibodies alters proliferation of cortical neural precursor cells, enlarges brain, and increases neuronal size in adult animals</article-title>. <source/><italic>Cereb. Cortex</italic>. <comment>[Epub ahead of print]</comment>
<uri xlink:href="http://dx.doi.org/10.1093/cercor/bhu291">doi:10.1093/cercor/bhu291</uri>
<pub-id pub-id-type="doi">10.1093/cercor/bhu291</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins-Silva</surname><given-names>C.</given-names></name>, <name><surname>De Jaeger</surname><given-names>X.</given-names></name>, <name><surname>Guzman</surname><given-names>M. S.</given-names></name>, <name><surname>Lima</surname><given-names>R. D. F.</given-names></name>, <name><surname>Santos</surname><given-names>M. S.</given-names></name>, <name><surname>Kushmerick</surname><given-names>C.</given-names></name>, <name><surname>Gomez</surname><given-names>M. V.</given-names></name>, <name><surname>Caron</surname><given-names>M. G.</given-names></name>, <name><surname>Prado</surname><given-names>M. A. M.</given-names></name> and <name><surname>Prado</surname><given-names>V. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Novel strains of mice deficient for the vesicular acetylcholine transporter: insights on transcriptional regulation and control of locomotor behavior</article-title>. <source/><italic>PLoS ONE</italic>
<volume>6</volume>, <fpage>e17611</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0017611</pub-id><pub-id pub-id-type="pmid">21423695</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martyn</surname><given-names>A. C.</given-names></name>, <name><surname>De Jaeger</surname><given-names>X.</given-names></name>, <name><surname>Magalhaes</surname><given-names>A. C.</given-names></name>, <name><surname>Kesarwani</surname><given-names>R.</given-names></name>, <name><surname>Goncalves</surname><given-names>D. F.</given-names></name>, <name><surname>Raulic</surname><given-names>S.</given-names></name>, <name><surname>Guzman</surname><given-names>M. S.</given-names></name>, <name><surname>Jackson</surname><given-names>M. F.</given-names></name>, <name><surname>Izquierdo</surname><given-names>I.</given-names></name>, <name><surname>Macdonald</surname><given-names>J. F.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Elimination of the vesicular acetylcholine transporter in the forebrain causes hyperactivity and deficits in spatial memory and long-term potentiation</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>109</volume>, <fpage>17651</fpage>-<lpage>17656</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1215381109</pub-id><pub-id pub-id-type="pmid">23045697</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarlane</surname><given-names>H. G.</given-names></name>, <name><surname>Kusek</surname><given-names>G. K.</given-names></name>, <name><surname>Yang</surname><given-names>M.</given-names></name>, <name><surname>Phoenix</surname><given-names>J. L.</given-names></name>, <name><surname>Bolivar</surname><given-names>V. J.</given-names></name> and <name><surname>Crawley</surname><given-names>J. N.</given-names></name></person-group> (<year>2008</year>). <article-title>Autism-like behavioral phenotypes in BTBR T+tf/J mice</article-title>. <source/><italic>Genes Brain Behav.</italic>
<volume>7</volume>, <fpage>152</fpage>-<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2007.00330.x</pub-id><pub-id pub-id-type="pmid">17559418</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mick</surname><given-names>E.</given-names></name>, <name><surname>McGough</surname><given-names>J.</given-names></name>, <name><surname>Loo</surname><given-names>S.</given-names></name>, <name><surname>Doyle</surname><given-names>A. E.</given-names></name>, <name><surname>Wozniak</surname><given-names>J.</given-names></name>, <name><surname>Wilens</surname><given-names>T. E.</given-names></name>, <name><surname>Smalley</surname><given-names>S.</given-names></name>, <name><surname>McCracken</surname><given-names>J.</given-names></name>, <name><surname>Biederman</surname><given-names>J.</given-names></name> and <name><surname>Faraone</surname><given-names>S. V.</given-names></name></person-group> (<year>2011</year>). <article-title>Genome-wide association study of the child behavior checklist dysregulation profile</article-title>. <source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>50</volume>, <fpage>807</fpage>-<lpage>817.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2011.05.001</pub-id><pub-id pub-id-type="pmid">21784300</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulligan</surname><given-names>A.</given-names></name>, <name><surname>Anney</surname><given-names>R. J. L.</given-names></name>, <name><surname>O'Regan</surname><given-names>M.</given-names></name>, <name><surname>Chen</surname><given-names>W.</given-names></name>, <name><surname>Butler</surname><given-names>L.</given-names></name>, <name><surname>Fitzgerald</surname><given-names>M.</given-names></name>, <name><surname>Buitelaar</surname><given-names>J.</given-names></name>, <name><surname>Steinhausen</surname><given-names>H.-C.</given-names></name>, <name><surname>Rothenberger</surname><given-names>A.</given-names></name>, <name><surname>Minderaa</surname><given-names>R.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Autism symptoms in Attention-Deficit/Hyperactivity Disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders</article-title>. <source/><italic>J. Autism Dev. Disord.</italic>
<volume>39</volume>, <fpage>197</fpage>-<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-008-0621-3</pub-id><pub-id pub-id-type="pmid">18642069</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolet</surname><given-names>C. M.</given-names></name> and <name><surname>Craig</surname><given-names>E. A.</given-names></name></person-group> (<year>1989</year>). <article-title>Isolation and characterization of STI1, a stress-inducible gene from Saccharomyces cerevisiae</article-title>. <source/><italic>Mol. Cell. Biol.</italic>
<volume>9</volume>, <fpage>3638</fpage>-<lpage>3646</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.9.9.3638</pub-id><pub-id pub-id-type="pmid">2674681</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordahl</surname><given-names>C. W.</given-names></name>, <name><surname>Braunschweig</surname><given-names>D.</given-names></name>, <name><surname>Iosif</surname><given-names>A.-M.</given-names></name>, <name><surname>Lee</surname><given-names>A.</given-names></name>, <name><surname>Rogers</surname><given-names>S.</given-names></name>, <name><surname>Ashwood</surname><given-names>P.</given-names></name>, <name><surname>Amaral</surname><given-names>D. G.</given-names></name> and <name><surname>Van de Water</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder</article-title>. <source/><italic>Brain Behav. Immun.</italic>
<volume>30</volume>, <fpage>61</fpage>-<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2013.01.084</pub-id><pub-id pub-id-type="pmid">23395715</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostapchenko</surname><given-names>V. G.</given-names></name>, <name><surname>Beraldo</surname><given-names>F. H.</given-names></name>, <name><surname>Mohammad</surname><given-names>A. H.</given-names></name>, <name><surname>Xie</surname><given-names>Y.-F.</given-names></name>, <name><surname>Hirata</surname><given-names>P. H. F.</given-names></name>, <name><surname>Magalhaes</surname><given-names>A. C.</given-names></name>, <name><surname>Lamour</surname><given-names>G.</given-names></name>, <name><surname>Li</surname><given-names>H.</given-names></name>, <name><surname>Maciejewski</surname><given-names>A.</given-names></name>, <name><surname>Belrose</surname><given-names>J. C.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-beta oligomer toxicity</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>33</volume>, <fpage>16552</fpage>-<lpage>16564</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3214-13.2013</pub-id><pub-id pub-id-type="pmid">24133259</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>D.</given-names></name></person-group> (<year>2002</year>). <article-title>Heat-shock protein 90, a chaperone for folding and regulation</article-title>. <source/><italic>Cell. Mol. Life Sci.</italic>
<volume>59</volume>, <fpage>1640</fpage>-<lpage>1648</lpage>. <pub-id pub-id-type="doi">10.1007/PL00012491</pub-id><pub-id pub-id-type="pmid">12475174</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roffe</surname><given-names>M.</given-names></name>, <name><surname>Beraldo</surname><given-names>F. H.</given-names></name>, <name><surname>Bester</surname><given-names>R.</given-names></name>, <name><surname>Nunziante</surname><given-names>M.</given-names></name>, <name><surname>Bach</surname><given-names>C.</given-names></name>, <name><surname>Mancini</surname><given-names>G.</given-names></name>, <name><surname>Gilch</surname><given-names>S.</given-names></name>, <name><surname>Vorberg</surname><given-names>I.</given-names></name>, <name><surname>Castilho</surname><given-names>B. A.</given-names></name>, <name><surname>Martins</surname><given-names>V. R.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Prion protein interaction with stress-inducible protein 1 enhances neuronal protein synthesis via mTOR</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>107</volume>, <fpage>13147</fpage>-<lpage>13152</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1000784107</pub-id><pub-id pub-id-type="pmid">20615969</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romberg</surname><given-names>C.</given-names></name>, <name><surname>Mattson</surname><given-names>M. P.</given-names></name>, <name><surname>Mughal</surname><given-names>M. R.</given-names></name>, <name><surname>Bussey</surname><given-names>T. J.</given-names></name> and <name><surname>Saksida</surname><given-names>L. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept)</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>31</volume>, <fpage>3500</fpage>-<lpage>3507</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5242-10.2011</pub-id><pub-id pub-id-type="pmid">21368062</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheufler</surname><given-names>C.</given-names></name>, <name><surname>Brinker</surname><given-names>A.</given-names></name>, <name><surname>Bourenkov</surname><given-names>G.</given-names></name>, <name><surname>Pegoraro</surname><given-names>S.</given-names></name>, <name><surname>Moroder</surname><given-names>L.</given-names></name>, <name><surname>Bartunik</surname><given-names>H.</given-names></name>, <name><surname>Hartl</surname><given-names>F. U.</given-names></name> and <name><surname>Moarefi</surname><given-names>I.</given-names></name></person-group> (<year>2000</year>). <article-title>Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine</article-title>. <source/><italic>Cell</italic>
<volume>101</volume>, <fpage>199</fpage>-<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80830-2</pub-id><pub-id pub-id-type="pmid">10786835</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D. F.</given-names></name>, <name><surname>Sullivan</surname><given-names>W. P.</given-names></name>, <name><surname>Marion</surname><given-names>T. N.</given-names></name>, <name><surname>Zaitsu</surname><given-names>K.</given-names></name>, <name><surname>Madden</surname><given-names>B.</given-names></name>, <name><surname>McCormick</surname><given-names>D. J.</given-names></name> and <name><surname>Toft</surname><given-names>D. O.</given-names></name></person-group> (<year>1993</year>). <article-title>Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70</article-title>. <source/><italic>Mol. Cell. Biol.</italic>
<volume>13</volume>, <fpage>869</fpage>-<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.13.2.869</pub-id><pub-id pub-id-type="pmid">8423808</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>I. N.</given-names></name>, <name><surname>Caetano</surname><given-names>F. A.</given-names></name>, <name><surname>Pinder</surname><given-names>J.</given-names></name>, <name><surname>Rodrigues</surname><given-names>B. R.</given-names></name>, <name><surname>Beraldo</surname><given-names>F. H.</given-names></name>, <name><surname>Ostapchenko</surname><given-names>V. G.</given-names></name>, <name><surname>Durette</surname><given-names>C.</given-names></name>, <name><surname>Pereira</surname><given-names>G. S.</given-names></name>, <name><surname>Lopes</surname><given-names>M. H.</given-names></name>, <name><surname>Queiroz-Hazarbassanov</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Regulation of stress-inducible phosphoprotein 1 nuclear retention by protein inhibitor of activated STAT PIAS1</article-title>. <source/><italic>Mol. Cell Proteomics</italic>
<volume>12</volume>, <fpage>3253</fpage>-<lpage>3270</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M113.031005</pub-id><pub-id pub-id-type="pmid">23938469</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taipale</surname><given-names>M.</given-names></name>, <name><surname>Jarosz</surname><given-names>D. F.</given-names></name> and <name><surname>Lindquist</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>HSP90 at the hub of protein homeostasis: emerging mechanistic insights</article-title>. <source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>11</volume>, <fpage>515</fpage>-<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2918</pub-id><pub-id pub-id-type="pmid">20531426</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taipale</surname><given-names>M.</given-names></name>, <name><surname>Tucker</surname><given-names>G.</given-names></name>, <name><surname>Peng</surname><given-names>J.</given-names></name>, <name><surname>Krykbaeva</surname><given-names>I.</given-names></name>, <name><surname>Lin</surname><given-names>Z.-Y.</given-names></name>, <name><surname>Larsen</surname><given-names>B.</given-names></name>, <name><surname>Choi</surname><given-names>H.</given-names></name>, <name><surname>Berger</surname><given-names>B.</given-names></name>, <name><surname>Gingras</surname><given-names>A.-C.</given-names></name> and <name><surname>Lindquist</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways</article-title>. <source/><italic>Cell</italic>
<volume>158</volume>, <fpage>434</fpage>-<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.05.039</pub-id><pub-id pub-id-type="pmid">25036637</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vorhees</surname><given-names>C. V.</given-names></name> and <name><surname>Williams</surname><given-names>M. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Morris water maze: procedures for assessing spatial and related forms of learning and memory</article-title>. <source/><italic>Nat. Protoc.</italic>
<volume>1</volume>, <fpage>848</fpage>-<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.116</pub-id><pub-id pub-id-type="pmid">17406317</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T.-H.</given-names></name>, <name><surname>Chao</surname><given-names>A.</given-names></name>, <name><surname>Tsai</surname><given-names>C.-L.</given-names></name>, <name><surname>Chang</surname><given-names>C.-L.</given-names></name>, <name><surname>Chen</surname><given-names>S.-H.</given-names></name>, <name><surname>Lee</surname><given-names>Y.-S.</given-names></name>, <name><surname>Chen</surname><given-names>J.-K.</given-names></name>, <name><surname>Lin</surname><given-names>Y.-J.</given-names></name>, <name><surname>Chang</surname><given-names>P.-Y.</given-names></name>, <name><surname>Wang</surname><given-names>C.-J.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation</article-title>. <source/><italic>Mol. Cell Proteomics</italic>
<volume>9</volume>, <fpage>1873</fpage>-<lpage>1884</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M110.000802</pub-id><pub-id pub-id-type="pmid">20501939</pub-id></mixed-citation>
</ref>
<ref id="DMM022525C54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name>, <name><surname>Bolivar</surname><given-names>V. J.</given-names></name> and <name><surname>Lawrence</surname><given-names>D. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Developmental exposure to mercury chloride does not impair social behavior of C57BL/6ÃBTBR F(1) mice</article-title>. <source/><italic>J. Immunotoxicol.</italic>
<volume>9</volume>, <fpage>401</fpage>-<lpage>410</lpage>. <pub-id pub-id-type="doi">10.3109/1547691X.2012.682663</pub-id><pub-id pub-id-type="pmid">22657747</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>